Matthew Goff Investment Advisor’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.8M | Sell |
115,209
-1,490
| -1% | -$174K | 2.5% | 13 |
|
|
2026
Q1 | $14M | Buy |
116,699
+332
| +0.3% | +$38.3K | 2.34% | 11 |
|
|
2025
Q4 | $12.2M | Sell |
116,367
-1,728
| -1% | -$162K | 2.17% | 13 |
|
|
2025
Q3 | $9.91M | Sell |
118,095
-901
| -0.8% | -$74.2K | 1.69% | 19 |
|
|
2025
Q2 | $9.42M | Sell |
118,996
-368
| -0.3% | -$29.3K | 1.74% | 19 |
|
|
2025
Q1 | $10.7M | Buy |
119,364
+2,860
| +2% | +$267K | 1.98% | 16 |
|
|
2024
Q4 | $11.6M | Buy |
116,504
+220
| +0.2% | +$22.7K | 2.15% | 14 |
|
|
2024
Q3 | $13.2M | Sell |
116,284
-43
| -0% | -$5.11K | 2.51% | 13 |
|
|
2024
Q2 | $14.4M | Sell |
116,327
-790
| -0.7% | -$102K | 2.94% | 10 |
|
|
2024
Q1 | $15.5M | Sell |
117,117
-1,842
| -2% | -$227K | 3.13% | 10 |
|
|
2023
Q4 | $13M | Sell |
118,959
-987
| -0.8% | -$102K | 2.88% | 12 |
|
|
2023
Q3 | $12.3M | Sell |
119,946
-982
| -0.8% | -$106K | 2.97% | 10 |
|
|
2023
Q2 | $14M | Sell |
120,928
-3,476
| -3% | -$395K | 3.28% | 8 |
|
|
2023
Q1 | $13.2M | Sell |
124,404
-2,604
| -2% | -$281K | 3.28% | 7 |
|
|
2022
Q4 | $14.1M | Sell |
127,008
-535
| -0.4% | -$54.7K | 3.67% | 7 |
|
|
2022
Q3 | $11M | Buy |
127,543
+1,442
| +1% | +$129K | 3.14% | 9 |
|
|
2022
Q2 | $11.5M | Buy |
126,101
+10,280
| +9% | +$911K | 3.1% | 11 |
|
|
2022
Q1 | $9.5M | Buy |
115,821
+12,581
| +12% | +$992K | 2.23% | 16 |
|
|
2021
Q4 | $7.91M | Sell |
103,240
-111
| -0.1% | -$8.84K | 1.81% | 20 |
|
|
2021
Q3 | $7.76M | Buy |
103,351
+3,200
| +3% | +$243K | 1.9% | 18 |
|
|
2021
Q2 | $7.79M | Buy |
100,151
+1,635
| +2% | +$122K | 1.98% | 19 |
|
|
2021
Q1 | $7.25M | Buy |
98,516
+40
| +0% | +$2.95K | 2.04% | 19 |
|
|
2020
Q4 | $7.69M | Buy |
98,476
+5,561
| +6% | +$425K | 2.29% | 16 |
|
|
2020
Q3 | $7.35M | Sell |
92,915
-409
| -0.4% | -$32K | 2.35% | 17 |
|
|
2020
Q2 | $6.89M | Buy |
93,324
+611
| +0.7% | +$46K | 2.26% | 14 |
|
|
2020
Q1 | $6.81M | Buy |
92,713
+3,103
| +3% | +$244K | 2.87% | 10 |
|
|
2019
Q4 | $7.78M | Sell |
89,610
-2,089
| -2% | -$172K | 2.88% | 12 |
|
|
2019
Q3 | $7.37M | Sell |
91,699
-2,060
| -2% | -$165K | 3.04% | 10 |
|
|
2019
Q2 | $7.5M | Sell |
93,759
-646
| -0.7% | -$49.5K | 3.21% | 10 |
|
|
2019
Q1 | $7.49M | Buy |
94,405
+194
| +0.2% | +$14.5K | 3.46% | 8 |
|
|
2018
Q4 | $6.87M | Buy |
94,211
+558
| +0.6% | +$39.4K | 3.49% | 10 |
|
|
2018
Q3 | $6.34M | Buy |
93,653
+947
| +1% | +$60.3K | 2.54% | 15 |
|
|
2018
Q2 | $5.37M | Buy |
92,706
+7,452
| +9% | +$420K | 2.1% | 19 |
|
|
2018
Q1 | $4.43M | Buy |
85,254
+2,764
| +3% | +$149K | 1.86% | 23 |
|
|
2017
Q4 | $4.43M | Buy |
82,490
+192
| +0.2% | +$10.6K | 1.91% | 23 |
|
|
2017
Q3 | $5.03M | Buy |
82,298
+2,286
| +3% | +$139K | 2.16% | 19 |
|
|
2017
Q2 | $4.89M | Sell |
80,012
-625
| -0.8% | -$38K | 4.39% | 7 |
|
|
2017
Q1 | $4.89M | Buy |
+80,637
| New | +$4.89M | 4.67% | 7 |
|
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
Matthew Goff Investment Advisor's MRK Position: Q2 2026 in Review
Matthew Goff Investment Advisor reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $174K and leaving 115,209 shares worth $14.8M. The position accounts for 2.5% of the portfolio, ranked #13.
Matthew Goff Investment Advisor first reported a position in MRK in Q1 2017 and has held it in 38 quarters since. The position peaked at $15.5M in Q1 2024. 966 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Matthew Goff Investment Advisor held 115,209 shares of Merck worth $14.8M as of Q2 2026.
- Matthew Goff Investment Advisor sold 1,490 Merck shares in Q2 2026, an estimated $174K.
- Merck made up 2.5% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #13 holding.
- Matthew Goff Investment Advisor first reported a position in Merck in Q1 2017 and has held it in 38 quarters since.
- Matthew Goff Investment Advisor's Merck position peaked at $15.5M in Q1 2024.
- 966 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.